Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Carmela Pera

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Plos One|February 22, 2017
Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment toolDanielle Ramsey, Mariacristina Scoto, Anna Mayhew, et al.
Neuromuscular Disorders : NMD|June 8, 2021
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersenGiorgia Coratti, Marika Pane, Simona Lucibello, et al.
European Journal of Pediatrics|April 18, 2024
Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome?Marika Pane, Giulia Stanca, Chiara Ticci, et al.
Muscle & Nerve|October 5, 2016
Revised upper limb module for spinal muscular atrophy: Development of a new moduleElena S Mazzone, Anna Mayhew, Jacqueline Montes, et al.
Eclinicalmedicine|December 17, 2024
Type I spinal muscular atrophy and disease modifying treatments: a nationwide study in children born since 2016Maria Carmela Pera, Giorgia Coratti, Marika Pane, et al.
Plos One|June 27, 2018
Ambulatory function in spinal muscular atrophy: Age-related patterns of progressionJacqueline Montes, Michael P McDermott, Elizabeth Mirek, et al.
Elife|September 20, 2021
SMA-miRs (miR-181a-5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samplesEmanuela Abiusi, Paola Infante, Cinzia Cagnoli, et al.
Neuromuscular Disorders : NMD|January 19, 2016
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trialsEugenio Mercuri, Richard Finkel, Jacqueline Montes, et al.
European Journal of Neurology|March 7, 2023
Type I spinal muscular atrophy patients treated with nusinersen: 4-year follow-up of motor, respiratory and bulbar functionMarika Pane, Giorgia Coratti, Valeria A Sansone, et al.
European Journal of Pediatrics|June 9, 2025
Italian validation of the SMA independence scale-upper limb moduleChiara Bravetti, Giorgia Coratti, Maria Carmela Pera, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Plos One|February 22, 2017
Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment toolDanielle Ramsey, Mariacristina Scoto, Anna Mayhew, et al.
Neuromuscular Disorders : NMD|June 8, 2021
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersenGiorgia Coratti, Marika Pane, Simona Lucibello, et al.
European Journal of Pediatrics|April 18, 2024
Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome?Marika Pane, Giulia Stanca, Chiara Ticci, et al.
Muscle & Nerve|October 5, 2016
Revised upper limb module for spinal muscular atrophy: Development of a new moduleElena S Mazzone, Anna Mayhew, Jacqueline Montes, et al.
Eclinicalmedicine|December 17, 2024
Type I spinal muscular atrophy and disease modifying treatments: a nationwide study in children born since 2016Maria Carmela Pera, Giorgia Coratti, Marika Pane, et al.
Plos One|June 27, 2018
Ambulatory function in spinal muscular atrophy: Age-related patterns of progressionJacqueline Montes, Michael P McDermott, Elizabeth Mirek, et al.
Elife|September 20, 2021
SMA-miRs (miR-181a-5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samplesEmanuela Abiusi, Paola Infante, Cinzia Cagnoli, et al.
Neuromuscular Disorders : NMD|January 19, 2016
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trialsEugenio Mercuri, Richard Finkel, Jacqueline Montes, et al.
European Journal of Neurology|March 7, 2023
Type I spinal muscular atrophy patients treated with nusinersen: 4-year follow-up of motor, respiratory and bulbar functionMarika Pane, Giorgia Coratti, Valeria A Sansone, et al.
European Journal of Pediatrics|June 9, 2025
Italian validation of the SMA independence scale-upper limb moduleChiara Bravetti, Giorgia Coratti, Maria Carmela Pera, et al.
Pageof 9